Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 10626
TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555289(US11344533, Compound 1-122 | 3-((1-(1-(2-aminoethy...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555302(US11344533, Compound 2-7 | 2-(3-(((6-chloro-2-cycl...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555301(US11344533, Compound 2-3 | 3-((6-chloro-2-cyclopro...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555300(US11344533, Compound 2-2 | 34(2-bromo-6-chloro-7-f...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555299(US11344533, Compound 2-1 | 34(2,6-dichloro-7-fluor...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555298(US11344533, Compound 1-131 | 3-(((6-chloro-2-cyclo...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555297(US11344533, Compound 1-130 | 3-((1-(1-(3-hydroxy-2...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555296(US11344533, Compound 1-129 | 3-((6-chloro-2-cyclop...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555295(US11344533, Compound 1-128 | 3-((1-(1-(6-aminoethy...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555294(BDBM50540913 | 34(6-chloro-2-cyclopropyl-1-(1-(eth...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555294(BDBM50540913 | 34(6-chloro-2-cyclopropyl-1-(1-(eth...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555293(US11344533, Compound 1-126 | 3-((6-chloro-2-cyclop...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555292(US11344533, Compound 1-125 | 34(1-(1-(4-amino-4-ox...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555291(US11344533, Compound 1-124 | 34(1-(1-(3-carboxypro...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555290(US11344533, Compound 1-123 | 3-((6-chloro-2-cyclop...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555274(US11344533, Compound 1-1 | 34(2,6-dichloro-1-(1-pr...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555288(US11344533, Compound 1-121 | 34(1-(1-(2-(carbamoyl...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555287(US11344533, Compound 1-120 | 3-((6-chloro-2-cyclop...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555286(US11344533, Compound 1-119 | 3-((6-chloro-2-cyclop...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555285(US11344533, Compound 1-92 | 6-((6-chloro-2-cyclopr...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555284(US11344533, Compound 1-49 | 3-((2,6-dichloro-7-flu...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555294(BDBM50540913 | 34(6-chloro-2-cyclopropyl-1-(1-(eth...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555282(US11344533, Compound 1-31 | 3-((2,6-dichloro-1-(1-...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555281(US11344533, Compound 1-16 | 3-((6-chloro-2-cyclopr...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555280(US11344533, Compound 1-13 | 3-((2,6-dichloro-7-flu...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555279(US11344533, Compound 1-10 | 3-((6-chloro-2-cyclopr...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555278(US11344533, Compound 1-7 | 34(2,6-dichloro-7-fluor...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555277(US11344533, Compound 1-4 | 3-((6-chloro-2-cyclopro...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555276(US11344533, Compound 1-3 | 34(6-chloro-2-cyano-1-(...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555275(US11344533, Compound 1-2 | 34(2-bromo-6-chloro-1-(...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent